Cargando…
Epidemiology and Prognosis of Coagulase-Negative Staphylococcal Endocarditis: Impact of Vancomycin Minimum Inhibitory Concentration
This study describes coagulase-negative staphylococcal (CoNS) infective endocarditis (IE) epidemiology at our institution, the antibiotic susceptibility profile, and the influence of vancomycin minimum inhibitory concentration (MIC) on patient outcomes. One hundred and three adults with definite IE...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4427314/ https://www.ncbi.nlm.nih.gov/pubmed/25961578 http://dx.doi.org/10.1371/journal.pone.0125818 |
_version_ | 1782370711687397376 |
---|---|
author | García de la Mària, Cristina Cervera, Carlos Pericàs, Juan M. Castañeda, Ximena Armero, Yolanda Soy, Dolors Almela, Manel Ninot, Salvador Falces, Carlos Mestres, Carlos A. Gatell, Jose M. Moreno, Asuncion Marco, Francesc Miró, José M. |
author_facet | García de la Mària, Cristina Cervera, Carlos Pericàs, Juan M. Castañeda, Ximena Armero, Yolanda Soy, Dolors Almela, Manel Ninot, Salvador Falces, Carlos Mestres, Carlos A. Gatell, Jose M. Moreno, Asuncion Marco, Francesc Miró, José M. |
author_sort | García de la Mària, Cristina |
collection | PubMed |
description | This study describes coagulase-negative staphylococcal (CoNS) infective endocarditis (IE) epidemiology at our institution, the antibiotic susceptibility profile, and the influence of vancomycin minimum inhibitory concentration (MIC) on patient outcomes. One hundred and three adults with definite IE admitted to an 850-bed tertiary care hospital in Barcelona from 1995-2008 were prospectively included in the cohort. We observed that CoNS IE was an important cause of community-acquired and healthcare-associated IE; one-third of patients involved native valves. Staphylococcus epidermidis was the most frequent species, methicillin-resistant in 52% of patients. CoNS frozen isolates were available in 88 patients. Vancomycin MICs of 2.0 μg/mL were common; almost all cases were found among S. epidermidis isolates and did not increase over time. Eighty-five patients were treated either with cloxacillin or vancomycin: 38 patients (Group 1) were treated with cloxacillin, and 47 received vancomycin; of these 47, 27 had CoNS isolates with a vancomycin MIC <2.0 μg/mL (Group 2), 20 had isolates with a vancomycin MIC ≥2.0 μg/mL (Group 3). One-year mortality was 21%, 48%, and 65% in Groups 1, 2, and 3, respectively (P=0.003). After adjusting for confounders and taking Group 2 as a reference, methicillin-susceptibility was associated with lower 1-year mortality (OR 0.12, 95% CI 0.02-0.55), and vancomycin MIC ≥2.0 μg/mL showed a trend to higher 1-year mortality (OR 3.7, 95% CI 0.9-15.2; P=0.069). Other independent variables associated with 1-year mortality were heart failure (OR 6.2, 95% CI 1.5-25.2) and pacemaker lead IE (OR 0.1, 95%CI 0.02-0.51). In conclusion, methicillin-resistant S.epidermidis was the leading cause of CoNS IE, and patients receiving vancomycin had higher mortality rates than those receiving cloxacillin; mortality was higher among patients having isolates with vancomycin MICs ≥2.0 μg/mL. |
format | Online Article Text |
id | pubmed-4427314 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-44273142015-05-21 Epidemiology and Prognosis of Coagulase-Negative Staphylococcal Endocarditis: Impact of Vancomycin Minimum Inhibitory Concentration García de la Mària, Cristina Cervera, Carlos Pericàs, Juan M. Castañeda, Ximena Armero, Yolanda Soy, Dolors Almela, Manel Ninot, Salvador Falces, Carlos Mestres, Carlos A. Gatell, Jose M. Moreno, Asuncion Marco, Francesc Miró, José M. PLoS One Research Article This study describes coagulase-negative staphylococcal (CoNS) infective endocarditis (IE) epidemiology at our institution, the antibiotic susceptibility profile, and the influence of vancomycin minimum inhibitory concentration (MIC) on patient outcomes. One hundred and three adults with definite IE admitted to an 850-bed tertiary care hospital in Barcelona from 1995-2008 were prospectively included in the cohort. We observed that CoNS IE was an important cause of community-acquired and healthcare-associated IE; one-third of patients involved native valves. Staphylococcus epidermidis was the most frequent species, methicillin-resistant in 52% of patients. CoNS frozen isolates were available in 88 patients. Vancomycin MICs of 2.0 μg/mL were common; almost all cases were found among S. epidermidis isolates and did not increase over time. Eighty-five patients were treated either with cloxacillin or vancomycin: 38 patients (Group 1) were treated with cloxacillin, and 47 received vancomycin; of these 47, 27 had CoNS isolates with a vancomycin MIC <2.0 μg/mL (Group 2), 20 had isolates with a vancomycin MIC ≥2.0 μg/mL (Group 3). One-year mortality was 21%, 48%, and 65% in Groups 1, 2, and 3, respectively (P=0.003). After adjusting for confounders and taking Group 2 as a reference, methicillin-susceptibility was associated with lower 1-year mortality (OR 0.12, 95% CI 0.02-0.55), and vancomycin MIC ≥2.0 μg/mL showed a trend to higher 1-year mortality (OR 3.7, 95% CI 0.9-15.2; P=0.069). Other independent variables associated with 1-year mortality were heart failure (OR 6.2, 95% CI 1.5-25.2) and pacemaker lead IE (OR 0.1, 95%CI 0.02-0.51). In conclusion, methicillin-resistant S.epidermidis was the leading cause of CoNS IE, and patients receiving vancomycin had higher mortality rates than those receiving cloxacillin; mortality was higher among patients having isolates with vancomycin MICs ≥2.0 μg/mL. Public Library of Science 2015-05-11 /pmc/articles/PMC4427314/ /pubmed/25961578 http://dx.doi.org/10.1371/journal.pone.0125818 Text en © 2015 García de la Mària et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article García de la Mària, Cristina Cervera, Carlos Pericàs, Juan M. Castañeda, Ximena Armero, Yolanda Soy, Dolors Almela, Manel Ninot, Salvador Falces, Carlos Mestres, Carlos A. Gatell, Jose M. Moreno, Asuncion Marco, Francesc Miró, José M. Epidemiology and Prognosis of Coagulase-Negative Staphylococcal Endocarditis: Impact of Vancomycin Minimum Inhibitory Concentration |
title | Epidemiology and Prognosis of Coagulase-Negative Staphylococcal Endocarditis: Impact of Vancomycin Minimum Inhibitory Concentration |
title_full | Epidemiology and Prognosis of Coagulase-Negative Staphylococcal Endocarditis: Impact of Vancomycin Minimum Inhibitory Concentration |
title_fullStr | Epidemiology and Prognosis of Coagulase-Negative Staphylococcal Endocarditis: Impact of Vancomycin Minimum Inhibitory Concentration |
title_full_unstemmed | Epidemiology and Prognosis of Coagulase-Negative Staphylococcal Endocarditis: Impact of Vancomycin Minimum Inhibitory Concentration |
title_short | Epidemiology and Prognosis of Coagulase-Negative Staphylococcal Endocarditis: Impact of Vancomycin Minimum Inhibitory Concentration |
title_sort | epidemiology and prognosis of coagulase-negative staphylococcal endocarditis: impact of vancomycin minimum inhibitory concentration |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4427314/ https://www.ncbi.nlm.nih.gov/pubmed/25961578 http://dx.doi.org/10.1371/journal.pone.0125818 |
work_keys_str_mv | AT garciadelamariacristina epidemiologyandprognosisofcoagulasenegativestaphylococcalendocarditisimpactofvancomycinminimuminhibitoryconcentration AT cerveracarlos epidemiologyandprognosisofcoagulasenegativestaphylococcalendocarditisimpactofvancomycinminimuminhibitoryconcentration AT pericasjuanm epidemiologyandprognosisofcoagulasenegativestaphylococcalendocarditisimpactofvancomycinminimuminhibitoryconcentration AT castanedaximena epidemiologyandprognosisofcoagulasenegativestaphylococcalendocarditisimpactofvancomycinminimuminhibitoryconcentration AT armeroyolanda epidemiologyandprognosisofcoagulasenegativestaphylococcalendocarditisimpactofvancomycinminimuminhibitoryconcentration AT soydolors epidemiologyandprognosisofcoagulasenegativestaphylococcalendocarditisimpactofvancomycinminimuminhibitoryconcentration AT almelamanel epidemiologyandprognosisofcoagulasenegativestaphylococcalendocarditisimpactofvancomycinminimuminhibitoryconcentration AT ninotsalvador epidemiologyandprognosisofcoagulasenegativestaphylococcalendocarditisimpactofvancomycinminimuminhibitoryconcentration AT falcescarlos epidemiologyandprognosisofcoagulasenegativestaphylococcalendocarditisimpactofvancomycinminimuminhibitoryconcentration AT mestrescarlosa epidemiologyandprognosisofcoagulasenegativestaphylococcalendocarditisimpactofvancomycinminimuminhibitoryconcentration AT gatelljosem epidemiologyandprognosisofcoagulasenegativestaphylococcalendocarditisimpactofvancomycinminimuminhibitoryconcentration AT morenoasuncion epidemiologyandprognosisofcoagulasenegativestaphylococcalendocarditisimpactofvancomycinminimuminhibitoryconcentration AT marcofrancesc epidemiologyandprognosisofcoagulasenegativestaphylococcalendocarditisimpactofvancomycinminimuminhibitoryconcentration AT mirojosem epidemiologyandprognosisofcoagulasenegativestaphylococcalendocarditisimpactofvancomycinminimuminhibitoryconcentration AT epidemiologyandprognosisofcoagulasenegativestaphylococcalendocarditisimpactofvancomycinminimuminhibitoryconcentration |